David F. Chang, MD, shares how to set realistic refractive IOL expectations and streamline patient counseling.

Timothy Janetos, MD, explained when to refer uveitis to a specialist and why access to uveitis care remains limited.

Taken together, these three responses point to gaps beyond the next therapy: in how academic medicine is valued, in what ...

Elizabeth A. Davis MD, FACS | Authors | The Eye Care Network delivers clinical news, expert interviews, and conference coverage across ophthalmology, retina, and optometry — uniting Ophthalmology ...

A higher risk of central serous chorioretinopathy and serous pigment epithelial detachment are associated with varicose veins.

Ryzumvi (phentolamine ophthalmic solution 0.75%) is approved for the treatment of presbyopia in adults. It is also approved for pharmacologically induced mydriasis produced by adrenergic agonists or ...

Steve Swalgen is national director of lab business, Santinelli International, Hauppauge, NY. Swalgen also is an advisory board member of the Optical Laboratory Association (OLA) and has developed and ...

Noah Banoub, a third year medical student, describes his journey into medicine and his choice of specialty. He recounted how MacTel type 2 went from being a diagnosis of exclusion without a therapy to ...

OT Roundup covers the optogenetics Nobel Prize, remigromig in DME with Veeral Sheth, MD, Stargardt disease and a total human ...

The FDA has approved Enspryng (satralizumab, Genentech) for thyroid eye disease (TED), making the drug the first subcutaneous ...

Talley Rostov is a partner at Northwest Eye Surgeons in Seattle, Washington, and serves as a board member and medical liaison for SightLife. She is a consultant for Glaukos.

Eclipse Life Sciences reports that its biodegradable 6-month fluocinolone acetonide implant met its primary safety end point ...